• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Will CMS’ Most Favored Nation Model Harm Patient Access to Care?

Will CMS’ Most Favored Nation Model Harm Patient Access to Care?

Dec 21, 2020 | Featured, Medicare

On November 20, 2020, the Center for Medicare & Medicaid Services’ (CMS) Innovation Center announced a mandatory national model that will evaluate whether reimbursing care providers for Medicare Part B drugs at rates that match international prices would reduce...
Patients with compromised immune systems are most at risk for coronavirus. Medicare blocks them from accessing in-home care.

Patients with compromised immune systems are most at risk for coronavirus. Medicare blocks them from accessing in-home care.

Apr 1, 2020 | Featured, Federal Issues, News

With a quarter of the world’s population under some form of lockdown, public health officials are stressing the importance of staying home and avoiding unnecessary trips to a hospital for minor ailments. But, staying at home isn’t an option for some patients most...

Categories

  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Uncategorized
  • Value Frameworks

Tags

340B Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance deferred action DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER immigration Imported Drugs Insurance design Joe Biden Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • New Government, Revised Rules? Seniors and Prescription Drug Cost-Sharing
  • S2 | E2: Mystery Hospital Costs 
  • S2 | E1: Will Democrats Help or Hurt Patients?
  • Episode 45: Pro-Patient Agenda Revealed
  • Episode 44: Patients Hurt by Most Favored Nation Rule

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now